EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Heart failure in autoimmune rheumatic diseases

Yuliya Fedorchenko iD, Olena Zimba iD, Mykhailo Fedorchenko iD, Bekzhan A Permenov iD, Burhan Fatih Kocyigit iD

Rheumatology International · 26.03.2026 · 46 (4)

DOI: 10.1007/s00296-026-06101-8 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Rheumatology International, online erschienen am 26.03.2026. Verfasst von Yuliya Fedorchenko und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathophysiology, Ivano-Frankivsk National Medical University, Ivano- Frankivsk, Ukraine. Hauptthemen laut MEDLINE: Rheumatic Diseases, Autoimmune Diseases, Heart Failure. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Health Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Heart failure (HF) is an increasingly important cause of morbidity and mortality in patients with autoimmune rheumatic diseases. Despite advances in cardiovascular prevention and treatment, HF incidence continues to rise in this population, driven by chronic systemic inflammation, immune-mediated myocardial injury, microvascular dysfunction, fibrosis, and treatment-related cardiotoxicity. Epidemiological studies consistently demonstrate a markedly increased HF risk across a broad spectrum of rheumatic diseases—including rheumatoid arthritis, systemic lupus erythematosus, systemic sclerosis, idiopathic inflammatory myopathies, ankylosing spondylitis, and primary Sjögren syndrome—often manifesting at younger age and independently of traditional cardiovascular risk factors. Subclinical myocardial involvement is frequent and commonly precedes overt HF, with preserved ejection fraction representing the dominant phenotype, particularly in inflammatory arthritis and systemic sclerosis. Advances in speckle-tracking echocardiography, cardiac magnetic resonance, and circulating biomarkers such as natriuretic peptides and cardiac troponins have enabled earlier detection and refined risk stratification. Although anti-inflammatory therapies, including conventional and biologic disease-modifying antirheumatic drugs, may mitigate HF risk, optimal control of traditional cardiovascular risk factors and cautious use of cardiotoxic agents remain essential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rheumatic DiseasesAutoimmune DiseasesHeart FailureHumansRisk FactorsAntirheumatic Agents

Stichwörter der Autor:innen

Autoimmune diseasesHeart failureInflammationMyocardial dysfunctionRheumatic diseasesRheumatoid arthritisSystemic lupus erythematosus

Substanzen

Antirheumatic Agents

Autor:innen und Institutionen

  • Department of Pathophysiology, Ivano-Frankivsk National Medical University, Ivano- Frankivsk, Ukraine.
  • Department of Rheumatology, Immunology and Internal Medicine, University Hospital in Kraków, Kraków, Poland.
  • National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland.
  • Department of Internal Medicine N2, Danylo Halytsky Lviv National Medical University, Lviv, Ukraine.
  • Department of Therapy, Family and Emergency Medicine, Faculty of Medicine, Ivano- Frankivsk National Medical University, Ivano- Frankivsk, Ukraine.
  • Department of Social Health Insurance and Public Health, South Kazakhstan Medical Academy, Shymkent, Kazakhstan.

ORCID-Profile: Yuliya Fedorchenko, Olena Zimba, Mykhailo Fedorchenko, Bekzhan A Permenov, Burhan Fatih Kocyigit

Förderung

  • University of Health Sciences

Zitieren

APA

Fedorchenko, Y., Zimba, O., Fedorchenko, M., Permenov, B. A., & Kocyigit, B. F. (2026). Heart failure in autoimmune rheumatic diseases. Rheumatology International, 46(4). https://doi.org/10.1007/s00296-026-06101-8

Vancouver

Fedorchenko Y, Zimba O, Fedorchenko M, Permenov BA, Kocyigit BF. Heart failure in autoimmune rheumatic diseases. Rheumatology International. 2026;46(4). doi:10.1007/s00296-026-06101-8

BibTeX
@article{Fedorchenko2026,
  author = {Fedorchenko, Yuliya and Zimba, Olena and Fedorchenko, Mykhailo and Permenov, Bekzhan A and Kocyigit, Burhan Fatih},
  title = {Heart failure in autoimmune rheumatic diseases},
  journal = {Rheumatology International},
  year = {2026},
  volume = {46},
  number = {4},
  doi = {10.1007/s00296-026-06101-8}
}
Kostenlos starten →